JPMorgan Resumes Nektar Therapeutics (NKTR) at Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

September 14, 2020 5:13 AM EDT
Get Alerts NKTR Hot Sheet
Price: $73.02 -3.82%

Rating Summary:
    20 Buy, 7 Hold, 5 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE

JPMorgan analyst Jessica Fye resumes coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Neutral rating and a price target of $26.00.


For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.


Shares of Nektar Therapeutics closed at $18.82 yesterday.


You May Also Be Interested In





Related Categories

New Coverage